Page 29 - Read Online
P. 29

SUMMARY AND FUTURE DIRECTIONS                       9.   Berberich S, Jensen V, Hvalby Ø, Seeburg PH, Köhr G. The role
                                                                  of NMDAR subtypes and charge transfer during hippocampal LTP
                                                                  induction. Neuropharmacology 2007;52:77‑86.
          As compared to patients abroad, Chinese patients    10.  Waxman EA, Lynch DR. N‑methyl‑D‑aspartate receptor subtypes:
          normally have a long course of recovery. There          multiple roles in excitotoxicity and neurological disease. Neuroscientist
          are several reasons for this, including inadequate      2005;11:37‑49.
          laboratory techniques, absence of standard operating   11.  Coyle JT. Glutamate and schizophrenia: beyond the dopamine
                                                                  hypothesis. Cell Mol Neurobiol 2006;26:365‑84.
          procedures for such type of treatment, insufficient drug   12.  Ruscheweyh R, Wilder‑Smith O, Drdla R, Liu XG, Sandkühler J.
          treatment, less experience in second-line treatment, and   Long‑term potentiation in spinal nociceptive pathways as a novel
          noncompliance of treatment from time to time. This is   target for pain therapy. Mol Pain 2011;7:20.
          a big challenge routinely faced by the neurologists in   13.  Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J.
          checkups, diagnosis, or treatment.                      Paraneoplastic limbic encephalitis: neurological symptoms,
                                                                  immunological findings and tumour association in 50 patients. Brain
                                                                  2000;123:1481‑94.
          Viral encephalitis and anti-NMDAR encephalitis have   14.  Vitaliani R, Mason W, Ances B, Zwerdling T, Jiang Z, Dalmau J.
          similar clinical symptoms such as headache, fever,      Paraneoplastic encephalitis, psychiatric symptoms, and
          mental disorder and seizures, and similar observations   hypoventilation in ovarian teratoma. Ann Neurol 2005;58:594‑604.
          in  MRI  or  EEG.  It  has  not  been  aligned  whether   15.  Dalmau J, Tüzün E, Wu HY, Masjuan J, Rossi JE, Voloschin A,
                                                                  Baehring  JM, Shimazaki  H, Koide  R, King  D, Mason  W,
          glucocorticoid should be used in the early treatment    Sansing LH, Dichter MA, Rosenfeld MR, Lynch DR. Paraneoplastic
          of viral encephalitis.  With the incidence of autoimmune   anti‑N‑methyl‑D‑aspartate receptor encephalitis associated with
          encephalopathies rising, we propose that patients with   ovarian teratoma. Ann Neurol 2007;61:25‑36.
          unconfirmed encephalitis could use glucocorticoid   16.  Dalmau  J, Gleichman  AJ, Hughes  EG, Rossi  JE, Peng  X,
                                                                  Lai M, Dessain SK, Rosenfeld MR, Balice‑Gordon R, Lynch DR.
          once they have a CSF puncture, and IVIg can also be     Anti‑NMDA‑receptor encephalitis: case series and analysis of the
          administered.                                           effects of antibodies. Lancet Neurol 2008;7:1091‑8.
                                                              17.  Zhou SN, Fu XX, Liu YM, Cao LL, Wang B, Li JJ, Li Y, Gao YJ,
                                                                  Gong XP. Analyse of one case of paraneoplastic limbic encephalitis
          B-lymphocyte depletion therapy mediated by anti-CD20    related with ovary teratoma. Chin J Neurol 2009;42:686‑8. (in
          monoclonal antibody has been a brilliant breakthrough   Chinese)
          in the treatment of various antibody-related autoimmune   18.  Dalmau J, Lancaster E, Martinez‑Hernandez E, Rosenfeld MR,
          diseases, such as anti-NMDAR encephalitis, rheumatoid   Balice‑Gordon R. Clinical experience and laboratory investigations
          arthritis, etc. It is important to investigate the possibility   in patients with anti‑NMDAR encephalitis.  Lancet Neurol
                                                                  2011;10:63‑74.
          of applying this therapy to other higher-incidence neural   19.  Lai M, Hughes EG, Peng X, Zhou L, Gleichman AJ, Shu H, Matà S,
          autoimmune diseases, such as ophthalmoneuromyelitis.    Kremens D, Vitaliani R, Geschwind MD, Bataller L, Kalb RG, Davis R,
          The vista is optimistic.                                Graus F, Lynch DR, Balice‑Gordon R, Dalmau J. AMPA receptor
                                                                  antibodies in limbic encephalitis alter synaptic receptor location.
                                                                  Ann Neurol 2009;65:424‑34.
          REFERENCES                                          20.  Lancaster E, Lai M, Peng X, Hughes E, Constantinescu R, Raizer J,
                                                                  Friedman D, Skeen MB, Grisold W, Kimura A, Ohta K, Iizuka T,
          1.   Lipton SA. Paradigm shift in neuroprotection by NMDA receptor   Guzman  M, Graus  F, Moss  SJ, Balice‑Gordon  R, Dalmau  J.
              blockade: memantine and beyond.  Nat Rev Drug Discov   Antibodies to the GABA (B) receptor in limbic encephalitis with
              2006;5:160‑70.                                      seizures: case series and characterisation of the antigen. Lancet
          2.   Dingledine R, Borges K, Bowie D, Traynelis SF. The glutamate   Neurol 2010;9:67‑76.
              receptor ion channels. Pharmacol Rev 1999;51:7‑61.  21.  Lai M, Huijbers MG, Lancaster E, Graus F, Bataller L, Balice‑Gordon R,
          3.   Cull‑Candy SG, Leszkiewicz DN. Role of distinct NMDA receptor   Cowell JK, Dalmau J. Investigation of LGI1 as the antigen in limbic
              subtypes at central synapses. Sci STKE 2004;2004:re16.  encephalitis previously attributed to potassium channels: a case
          4.   Wolosker H. D‑serine regulation of NMDA receptor activity. Sci STKE   series. Lancet Neurol 2010;9:776‑85.
              2006;2006:pe41.                                 22.  Prüss H, Dalmau J, Harms L, Höltje M, Ahnert‑Hilger G, Borowski K,
          5.   McRoberts JA, Coutinho SV, Marvizón JC, Grady EF, Tognetto M,   Stoecker  W, Wandinger  KP. Retrospective analysis of NMDA
              Sengupta JN, Ennes HS, Chaban VV, Amadesi S, Creminon C,   receptor antibodies in encephalitis of unknown origin. Neurology
              Lanthorn T, Geppetti P, Bunnett NW, Mayer EA. Role of peripheral   2010;75:1735‑9.
              N‑methyl‑D‑aspartate (NMDA) receptors in visceral nociception in   23.  Granerod  J, Ambrose  HE, Davies  NW, Clewley  JP, Walsh  AL,
              rats. Gastroenterology 2001;120:1737‑48.            Morgan D, Cunningham R, Zuckerman M, Mutton KJ, Solomon T,
          6.   Suen PC, Wu K, Xu JL, Lin SY, Levine ES, Black IB. NMDA receptor   Ward KN, Lunn MP, Irani SR, Vincent A, Brown DW, Crowcroft
              subunits in the postsynaptic density of rat brain: expression and   NS; UK Health Protection Agency (HPA) Aetiology of Encephalitis
              phosphorylation by endogenous protein kinases. Brain Res Mol   Study  Group.  Causes of  encephalitis  and  differences in  their
              Brain Res 1998;59:215‑28.                           clinical presentations in England: a multicentre, population‑based
          7.   Gladding CM, Raymond LA. Mechanisms underlying NMDA receptor   prospective study. Lancet Infect Dis 2010;10:835‑44.
              synaptic/extrasynaptic distribution and function. Mol Cell Neurosci   24.  Hu  XS, Ouyang  M, Li  H, Li  DF, Dou  WB, Wu  XY, Chen  W,
              2011;48:308‑20.                                     Xu SQ. Three cases of anti‑NMDA receptor encephalitis. Chin J
          8.   Harris  AZ,  Pettit  DL.  Recruiting  extrasynaptic  NMDA  receptors   Neuroimmunol Neurol 2014;21:66‑8. (in Chinese)
              augments synaptic signaling. J Neurophysiol 2008;99:524‑33.  25.  Chen L, Zhu FQ, Zhu JH, Li XL. Anti‑NMDA receptor encephalitis:


            22                                                 Neuroimmunol Neuroinflammation | Volume 1 | Issue 1 | June 2014
   24   25   26   27   28   29   30   31   32   33   34